Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct;94(5):989-1002, vii-viii.
doi: 10.1016/j.suc.2014.07.003. Epub 2014 Aug 5.

Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence

Amy A Mrazek  1 , Celia Chao  2
Affiliations
Review

Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence

Amy A Mrazek et al. Surg Clin North Am. 2014 Oct.

Abstract

The number of melanoma survivors in the United States continues to steadily increase 2.6% per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.

Keywords: Management of recurrence; Melanoma survivorship; Surveillance and follow-up; Survival prognosis.

PubMed Disclaimer

References

    1. Howlader N, Noone AM, Krapcho M, et al. [Accessed March 6, 2014];Surveillance, Epidemiology, and End Results (SEER) Cancer Statistics Review, 1975–2010. Available at: http://seer.cancer.gov/csr/1975_2010/
    1. MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol. 2009;20(Suppl 6):vi1–7. - PMC - PubMed
    1. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27:3–9. - PubMed
    1. Yang GB, Barnholtz-Sloan JS, Chen Y, et al. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer. Arch Dermatol. 2011;147:1395–402. - PubMed
    1. Freedman DM, Miller BA, Tucker MA. New malignancies following melanoma of the skin, eye melanoma, and non-melanoma eye cancer. In: Curtis RE, Freedman DM, Ron E, et al., editors. New Malignancies Amoung Cancer Survivors: SEER Cancer Registries, 1973–2000. National Cancer Institute; Bethesda, MD: 2006. pp. 339–62.

MeSH terms